Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-04-03

FDA Approved: BALSALAZIDE DISODIUM — Original Application (Carnegie Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original ANDA for balsalazide disodium as a generic treatment for ulcerative colitis, manufactured by Carnegie Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BALSALAZIDE DISODIUM (balsalazide disodium)

Snippet

ORIG AP for BALSALAZIDE DISODIUM (BALSALAZIDE DISODIUM)